N0337: Phase II study of capecitabine in combination with vinorelbine and trastuzumab for the first or second treatment of HER2+metastatic breast cancer
- Citation:
- J Clin Oncol vol 27 (15) abstr 120
- Meeting Instance:
- ASCO 2009
- Year:
- 2009
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 786
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- W. Tan J. Allred M. Salim P. Flynn J. W. Kugler P. J. Stella M. Wiesenfeld A. M. Bernath Jr T. R. Fitch E. A. Perez
- Networks:
- Study
- NCCTG-N0337
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: